FindTrial
Sign In

The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery

The Effect of Premedication Methods to be Applied to Prevent Preoperative Anxiety in Patients Who Will be Operated for Breast Cancer, on Postoperative Anxiety and Pain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05647642
Enrollment
80
Registered
2022-12-12
Start date
2022-10-16
Completion date
2023-01-30
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery

Brief summary

In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery.

Detailed description

In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery. The STAI-1(State Trait Anxiety İnventory ) form and APAIS (Amsterdam Preoperative Anxiety and İnformation Scale) scale were filled in for all preoperative patients. Afterwards, the patients were treated with either midazolam or dexmedetothymidine, depending on the anesthesiologist's preference. After administration, he was taken to surgery. As intraoperative analgesics, 2 mg/kg tramadol and 15 mg/kg paracetamol were administered to all patients. postoperative recovery time (aldrete 10), 1., 2.,6.,12.,24. VAS score, postoperative nausea-vomiting scale, STAI-1(State Trait Anxiety İnventory ) form, first need time if postoperative analgesic was needed, and 24-hour total analgesic consumption were recorded. It was aimed to examine the effects of different premedications on postoperative pain and anxiety

Interventions

DRUGPrecedex and dormicum

Premedication

Sponsors

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA 1-2-3 * 18-65 aged * Female patients

Exclusion criteria

* Under 18 years old and over 65 years old * Having a history of cerebrovascular disease illiteracy * Have visual and auditory problems İnability to cooperate with cognitive function test * Having emergency surgery * Those who are unable to read, understand and sign the consent form * Patients deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
effect of premedication on postoperative pain and anxiety scoresNovember 2022-December 2022

Countries

Turkey (Türkiye)

Contacts

Primary ContactSeyda ARİ
seyda93.ari@yandex.com+905382598442
Backup ContactGuldeniz ARGUN
guldargun@yahoo.com+905336230405

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026